report ep toward higher end guidanc though
consolid revenu came street model organ revenu
growth like miss bullish hope
diabet number shi street model given disproportion
investor focu success libr launch line item particular
could afford miss rais revenu estim modestli
upsid leav ep forecast unchang thesi
unchang believ mani arrow abt quiver
feel minim execut risk given share extraordinari run
mani approv expect gotten quit lofti share
like move meaning beat maintain
neutral rate though feel fair valu dollar higher current
segment result bit mix revenu standout includ
solid ou diabet result driven libr momentum better aler
result thank flu strong electrophysiolog momentum
cardiac map confirm flip side diabet revenu
vs consensu though manag report
 libr launch good start pick-up enough
off-set double-digit declin within bgm busi roughli half
busi addit establish pharma fell short
expect weak russia lesser extent mexico
cost growth
come toward high end previous discuss rang
management mention ad patient mix
manag note nice balanc competit win cgm-
nave patient take diabet number
account steeper declin bgm initi model
valuat maintain neutral rate risk page
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
report revenu forecast
expect diagnost segment drove greatest upsid vs model
part due strong flu season flip side establish pharma came
lower consensu due weak russia establish
pharmaceut grew quarter organ basi without russia
manag note growth would closer
medic devic segment came forecast better result
seen electrophysiolog vascular ou structur heart ou
diabet result in-lin mention previous diabet
sale total come short consensu
forecast diabet result impact typic season
drop-off patient tend stockpil suppli latter part
year deduct met though libr
except launch per manag commentari contribut
enough off-set doubl digit declin seen blood glucos
monitor busi estim half ww diabet
busi
ebit margin fairli similar forecast line
incom help drive penni beat vs forecast
actualsbtig estimate variancetot incom net bpssg spend bpsr spend bpsebit bpstax bpssourc btig estim compani filingsvari
make number chang estim revenu flow
upsid rais estim diagnost nutrit
electrophysiolog structur heart vascular trim ou
neuromod estim slightli trend final lower
diabet forecast account steeper declin bgm busi
keep margin estim rel unchang maintain
ep forecast
abbott rate neutral share appreci last year
strong new product launch expect although like
product think upsid investor expect decreas feel
target multipl ntm earn appropri mirror histor
rang last year appli mo revenu estim
yield enough upsid buy rate btig provid price
target neutral-r stock
risk rate includ multipl expans competit healthcar polici
chang currenc fluctuat healthcar fall favor fda
regulatori agenc product delay failur execut merger synergi
exhibit comp tabl large-cap peer
net ep gross bpsadj ebit bp btig estim compani filingsnewold changentm johnsonjnjsel fishertmobuy bdxnot scientificbsxbuy factset data btig estimatespr ex-amortcompanytickerr ptpricemarket cap bev/salesev/ebitdacagr
abbott incom statement sale ex oper interest incom incom tax expens net ep methodology/abt share net incom ep incl disc marginsgross expensescog oper expens ep btig estim compani report
abbott segment laboratori y/i laboratori y/i growth laboratori y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth diagnost y/i diagnost y/i growth diagnost y/i growthy/i growth oper adj aleretot y/i y/i growth y/i growth oper adj btig estim
abbott segment devicesrhythm manag y/i manag y/i growth manag y/i growth y/i y/i growth y/i growth failur y/i failur y/i growth failur y/i growth y/i y/i growth y/i growth heart y/i heart y/i growth heart y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth devic y/i devic y/i growth devic y/i growth totaltot report segment us y/i report segment y/i report segment ww y/i btig estim compani adjust stj acquisit optic divestitur
btig cover compani mention report
appendix analyst certif import disclosur
